Clinical Nutrition Market Report 2026

The clinical nutrition market size has grown strongly in recent years. It will grow from $64.37 billion in 2025 to $70.42 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to limited availability of specialized nutrition products, growing hospital and clinical infrastructure, rising prevalence of chronic diseases, increasing awareness of malnutrition, adoption of standard enteral and parenteral solutions.

The clinical nutrition market size is expected to see strong growth in the next few years. It will grow to $102.42 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to development of disease-specific and personalized nutrition formulas, expansion of home care and tele-nutrition services, increasing adoption of digital monitoring tools, rising geriatric and pediatric population, growing government and private initiatives for clinical nutrition. Major trends in the forecast period include rising demand for infant nutrition products and specialized formulas, increasing adoption of parenteral and enteral nutrition in hospitals, growth in disease-specific nutritional therapies for cancer and metabolic disorders, expansion of geriatric and adult clinical nutrition programs, integration of home care and remote nutritional monitoring services.

The expanding geriatric population is expected to drive the growth of the clinical nutrition market in the coming years. The geriatric population includes individuals aged 65 years and above, who are generally more vulnerable to age-related health issues and often require specialized medical and nutritional care. Growth in this population is largely attributed to increased life expectancy, as advances in healthcare, nutrition, and living standards have enabled people to live longer than earlier generations. Clinical nutrition supports the elderly by delivering customized dietary solutions that help maintain overall health, prevent malnutrition, and manage chronic and age-related conditions. For example, in October 2025, according to the Office for National Statistics, a UK-based producer of official statistics, the number of people aged 90 years and over in the UK reached 625,000 in 2024, up from 612,000 in mid-2023, representing a 2.2% increase. Consequently, the rising geriatric population is contributing to the growth of the clinical nutrition market.

Major companies operating in the clinical nutrition market are increasingly emphasizing technological innovations, such as semi-solid enteral nutrition formulations, to address the growing need for patient-friendly, efficient, and physiologically suitable feeding options, particularly for individuals with impaired oral intake or reduced energy requirements. Semi-solid nutrition products are formulated with a gel-like consistency rather than a liquid form, which helps lower the risk of reflux, enables slower gastric emptying, and improves patient tolerance when administered via feeding tubes compared with conventional low-viscosity liquid formulas. For instance, in January 2025, Otsuka Pharmaceutical Factory Inc., a Japan-based clinical nutrition company, introduced ENOSOLID Semi Solid for Enteral Use. This prescription semi-solid formula contains essential macronutrients, vitamins, trace elements, L-carnitine to support energy metabolism, and inulin as a soluble dietary fiber. It is designed for patients with lower maintenance energy needs, administered through a gastric tube, and formulated to reduce reflux while ensuring adequate nutrient delivery in smaller volumes. This development reflects increasing demand for tailored nutritional therapies among post-operative, elderly, and debilitated patients who benefit from easier-to-manage and physiologically aligned enteral feeding solutions.

In May 2025, Danone S.A., a France-based provider of food products and specialized clinical nutrition, acquired a majority stake in Kate Farms Inc. for an undisclosed amount. Through this acquisition, Danone aims to expand its medical nutrition presence in the United States by incorporating Kate Farms’ plant-based and organic nutrition products, thereby extending its reach across both clinical and everyday nutrition segments. Kate Farms Inc. is a US-based company that manufactures plant-based, organic medical nutrition formulas and shakes for patients with specific dietary and feeding requirements.

Major companies operating in the clinical nutrition market are Abbott Laboratories, Nestlé S.A., Baxter Healthcare Ltd., B. Braun Melsungen AG, Perrigo Company plc, Fresenius Kabi AG, Danone S.A., Pfizer Inc., Mead Johnson Nutrition Company, Hero Nutritionals, Gentiva Health Services Inc., H.J. Heinz Company, Ajinomoto Co. Inc., Lonza Group Ltd., GlaxoSmithKline plc, BASF SE, Kendal Nutricare, DuPont Nutrition & Health, American HomePatient, Reckitt Benckiser Group plc, Vivante Health.

North America was the largest region in the clinical nutrition market in 2025. The regions covered in the clinical nutrition market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical nutrition market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the clinical nutrition market by increasing costs of imported raw materials, specialized nutritional formulations, and medical-grade packaging. Segments such as parenteral nutrition solutions and infant nutrition products are most affected, particularly in North America, Europe, and Asia-Pacific regions reliant on imports. This has led to higher production costs and supply chain challenges. On the positive side, tariffs have encouraged local manufacturing, innovation in cost-effective nutritional products, and development of domestic production capacities.

The clinical nutrition market research report is one of a series of new reports that provides clinical nutrition market statistics, including clinical nutrition industry global market size, regional shares, competitors with a clinical nutrition market share, detailed clinical nutrition market segments, market trends and opportunities, and any further data you may need to thrive in the clinical nutrition industry. This clinical nutrition market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Clinical nutrition is a discipline that concentrates on the prevention, diagnosis, and management of nutritional and metabolic disorders associated with acute and chronic diseases, as well as conditions resulting from imbalances in nutrients and energy. It emphasizes assessing whether an individual is receiving adequate nutrition and ensuring the body is supplied with the appropriate type of nourishment to support overall health.

The primary product categories in clinical nutrition include infant nutrition, parenteral nutrition, and enteral nutrition. Infant nutrition is specifically designed to meet the distinct nutritional requirements of infants and toddlers and to support healthy early development. The various routes of administration include oral, enteral, and parenteral, and these products are used in conditions such as cancer, neurological diseases, gastrointestinal disorders, metabolic disorders, and others. They are utilized by pediatric, adult, and geriatric populations.

The clinical nutrition market includes revenues earned by entities by managing nutritional changes in patients linked to chronic diseases and by understanding the needs of individuals and groups for energy and nutrients. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.